AI watches hospital Patients' vital signs to catch decline early
NCT ID NCT07649642
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether continuous, AI-driven monitoring of vital signs can help hospital staff spot when a patient's condition is worsening. About 100 adults at risk of clinical deterioration will wear sensors that track their vital signs in real time. Nurses and doctors will rate how relevant and helpful the alerts are, aiming to improve patient safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous vital sign monitoring device with AI algorithm
What this could lead to
If successful, this could improve how hospitals detect early signs of patient decline, potentially leading to faster care.
What could go wrong
This is a small, early-stage study focused on staff feedback, not patient outcomes. The AI may not improve care or could cause alarm fatigue.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DETERIORATION, CLINICAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bispebjerg Hospital
Copenhagen, 2400, Denmark
-
Rigshospitalet
Copenhagen, 2100, Denmark